|Articles|December 1, 2016
- BioPharm International-12-01-2016
- Volume 29
- Issue 12
BioPharm International, December 2016 Issue (PDF)
Click the title above to open the BioPharm International December 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Cross Contamination in Biopharmaalmost 9 years ago
Expression systems for the development of biosimilarsalmost 9 years ago
Large-Scale Protein Expression in Baculovirus-Infected Insect Cellsalmost 9 years ago
Automated Microscope for Multimodal Imagingalmost 9 years ago
Chromatograph Enables Fast Recovery of Target Compoundsalmost 9 years ago
A Coiled Flow Inversion Reactor Enables Continuous Processingalmost 9 years ago
Nurturing the Relationship Between Industry and Regulatorsalmost 9 years ago
Stimulating Biosimilar Uptake: Implications for Manufacturersalmost 9 years ago
Pharmaceutical Manufacturers Gear Up for Political ChangeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
3
Biopharma’s Digital Hopes Versus Actual Implementation
4
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
5